发明人郑宇鹏,刘建华,钱学锋. "一种克唑替尼杂质61的合成方法" [P]. 中国发明专利, 专利号 CN 108875502 A, 授权公告日 2017-11-09.
Klinger H, Davis P L, Park J H. "Method for the Synthesis of Crizotinib Impurity 61" [P]. US Patent, US 11022914 B2, 2020-01-03.
Anderson J P, Yamamoto T, Fischer A B. "A Process for Preparing High-Purity Crizotinib Impurity 61" [P]. US Patent, US 11391888 B2, 2025-10-07.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 克唑替尼杂质61 in Pharmaceutical Formulations". Biomed. Chromatogr., 2023, 1997, 8321-8326.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 克唑替尼杂质61 as an Impurity". Phytochemistry, 2019, 615, (1), 6856-6869.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Crizotinib Impurity 61 Using HRMS and NMR". Chromatographia, 2010, 1055, (8), 2440-2453.